GB2023133B - Heterocyclic derivatives - Google Patents

Heterocyclic derivatives

Info

Publication number
GB2023133B
GB2023133B GB7913730A GB7913730A GB2023133B GB 2023133 B GB2023133 B GB 2023133B GB 7913730 A GB7913730 A GB 7913730A GB 7913730 A GB7913730 A GB 7913730A GB 2023133 B GB2023133 B GB 2023133B
Authority
GB
United Kingdom
Prior art keywords
heterocyclic derivatives
heterocyclic
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7913730A
Other languages
English (en)
Other versions
GB2023133A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to IE846/79A priority Critical patent/IE48750B1/en
Publication of GB2023133A publication Critical patent/GB2023133A/en
Application granted granted Critical
Publication of GB2023133B publication Critical patent/GB2023133B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB7913730A 1978-04-26 1979-04-19 Heterocyclic derivatives Expired GB2023133B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE846/79A IE48750B1 (en) 1978-04-26 1979-08-08 Heterocyclic derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1646878 1978-04-26

Publications (2)

Publication Number Publication Date
GB2023133A GB2023133A (en) 1979-12-28
GB2023133B true GB2023133B (en) 1982-09-08

Family

ID=10077887

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7913730A Expired GB2023133B (en) 1978-04-26 1979-04-19 Heterocyclic derivatives

Country Status (5)

Country Link
JP (1) JPS54160391A (de)
KR (1) KR840000420B1 (de)
BE (1) BE875846A (de)
GB (1) GB2023133B (de)
ZA (1) ZA792021B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390701A (en) 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
US4395553A (en) 1981-05-18 1983-07-26 Bristol-Myers Company Chemical compounds

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18379A (en) * 1979-03-02 1985-06-19 Glaxo Group Ltd Triazole acylamines and pharmaceutical compositions thereof
FR2477150A1 (fr) * 1980-02-28 1981-09-04 Glaxo Group Ltd Nouveaux derives heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les comportant
AU548426B2 (en) * 1980-08-27 1985-12-12 Glaxo Group Limited 3-amino-(1,2,4)-triazoles
US4338453A (en) 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4546188A (en) * 1981-05-18 1985-10-08 Bristol-Myers Company Substituted 1,2-diaminocyclobutene-3,4-diones
US4539316A (en) * 1981-05-18 1985-09-03 Bristol-Myers Company Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones
AU8480982A (en) * 1981-06-11 1983-01-13 Glaxo Group Limited 1,2,4-triazole derivatives with histamine h2-blocking activity
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
US4495193A (en) * 1982-12-30 1985-01-22 Biomeasure, Inc. Imidazole compounds which reduce gastric acid secretion
US4565815A (en) * 1982-12-30 1986-01-21 Biomeasure, Inc. Pyrazolo[1,5-a]-1,3,5-triazines
DK169255B1 (da) * 1983-02-22 1994-09-26 American Home Prod Analogifremgangsmåde til fremstilling af thieno-isothiazol-1,1-dioxid-derivater og farmaceutisk acceptable salte heraf
US4772622A (en) * 1983-03-25 1988-09-20 Merck & Co., Inc. 3,5-diamino-1,2,4-oxidiazoles as gastric secretion inhibitors
US4567191A (en) * 1983-06-07 1986-01-28 Merck & Co., Inc. Amino-phenyl-thiadiazoledioxides as gastric secretion inhibitors
HU193253B (en) * 1985-01-29 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing 3,5-diamino-1,2,4-triazole derivatives
US4927968A (en) * 1987-05-14 1990-05-22 Bristol-Myers Company Chemical intermediates and process

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390701A (en) 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
US4395553A (en) 1981-05-18 1983-07-26 Bristol-Myers Company Chemical compounds

Also Published As

Publication number Publication date
GB2023133A (en) 1979-12-28
JPS54160391A (en) 1979-12-19
KR840000420B1 (ko) 1984-04-02
JPH0351708B2 (de) 1991-08-07
ZA792021B (en) 1980-06-25
KR830000694A (ko) 1983-04-18
BE875846A (fr) 1979-10-25

Similar Documents

Publication Publication Date Title
GB2033893B (en) Tetrazolylalkoxycarbostyril derivatives
PH19534A (en) Heterocyclic derivatives
ZA795239B (en) Heterocyclic compounds
GB2012759B (en) Thienohydantoin derivatives
GB2030979B (en) Heterocyclic derivatives
GB2023133B (en) Heterocyclic derivatives
JPS54154426A (en) Heterocyclic compounds
GB2022079B (en) L-leucyl-4-hydroxyanilide derivatives
ZA801151B (en) Heterocyclic derivatives
ZA792242B (en) Heterocyclic compounds
GB2038326B (en) Acylaniline derivatives
GB2018757B (en) 3-phenyltetrahydropyridine derivatives
GB2017708B (en) Steroid-spirooxazolidinone derivatives
GB2036744B (en) Eburnane derivatives
GB2019843B (en) N-alkenylmoranoline derivatives
GB2017691B (en) 2-hydroxymethyl-pyrazine derivatives
GB2029851B (en) Heterocyclic compounds
GB2024806B (en) Onomycin derivatives
GB2052477B (en) Carbamoyl-piperazine derivatives
GB2023574B (en) N-cyano-azomethine derivatives
GB2013187B (en) Phenylpyrol derivatives
GB2027707B (en) Heterocyclic compounds
GB2013654B (en) Benziosothiazole derivatives
GB2044251B (en) Phenoxypropanolamine derivatives
GB2037764B (en) 7-methoxycepgalosporin derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee